Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ECCO 15 - ESMO 34 /
Targeted agents in the treatment of advanced NSCLC

20th - 24th Sep 2009

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 02.11.09
Views: 12601

Prof Johan Vansteenkiste - Leuven University Hospital, Belgium

Targeted agents in the treatment of advanced NSCLC. New data on Zactima. Zactima in combination with standard chemotherapy. Immunotherapy and the MAGE-A3 vaccine. Speaking at ECCO 15 - ESMO 34, Berlin, 2009.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation